|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,895 KRW | -2.42% |
|
-1.61% | -9.33% |
Icure Pharmaceutical Incorporation (KOSDAQ:A175250) announces a share repurchase program. Under the program, the company will repurchase up to 40,323 shares. The purpose of the program is to enhance the shareholder value through stabilization of stock price.
The program is valid until March 25, 2022. As of February 24, 2022, the company had 131,796 shares in treasury within scope available for dividend and 5,885 shares in treasury through other repurchase.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.33% | 52.72M | |
| +8.16% | 18.57B | |
| 0.00% | 16.6B | |
| -4.59% | 10.49B | |
| -10.23% | 9.88B | |
| -1.52% | 6.53B | |
| +4.23% | 5.67B | |
| -4.74% | 4.22B | |
| -11.20% | 3.97B | |
| -3.87% | 3.54B |
ICURE PHARMACEUTICAL INCORPORATION 
